Main

processing priority

3

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-09 01:22:30

expired found date

-

created at

2024-06-26 20:48:39

updated at

2026-01-06 21:39:27

Domain name statistics

length

11

crc

60676

tld

826

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

94587248

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

123255

mp size raw text

4361

mp inner links count

6

mp inner links status

20 (imported)

Open Graph

title

Homepage

description

NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer

site name

NICE website: The National Institute for Health and Care Excellence

author

updated

2026-01-02 01:03:01

raw text

Homepage | NICE Skip to content Accessibility help Search NICE… Skip to content Menu Sign in Guidance Standards and indicators Life sciences British National Formulary (BNF) British National Formulary for Children (BNFC) Clinical Knowledge Summaries (CKS) About We produce useful and usable guidance for the NHS and wider health and care system. Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer. Find guidance Latest from NICE NICE leads the way in approving breakthrough treatment for multiple myeloma People in England will become the first in the world to receive belantamab mafodotin for this indication following our recommendation and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approval earlier this year. News 13 June 2025 ‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes Around 20...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medicine [en] (226)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

3454

text words

617

text unique words

290

text lines

101

text sentences

25

text paragraphs

5

text words per sentence

24

text matched phrases

2

text matched dictionaries

1

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

10 (sitemap found, awaiting processing)

sitemap review version

2

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2025-06-18 11:16:05

sitemap process date

-

sitemap first import date

-

sitemap last import date

-